linagliptin
Showing 1 - 25 of 81
Kidney Transplant; Complications, Diabetes Trial (Empagliflozin 25 MG, Linagliptin)
Not yet recruiting
- Kidney Transplant; Complications
- Diabetes Mellitus
- Empagliflozin 25 MG
- Linagliptin
- (no location specified)
Oct 18, 2023
Type 2 Diabetes Trial in Buffalo (Linagliptin, Placebo)
Completed
- Type 2 Diabetes
- Linagliptin
- Placebo
-
Buffalo, New YorkECMC Ambulatory Center, 3rd Floor
Feb 2, 2022
Type 2 Diabetes, Mild Cognitive Impairment Trial in Nanjing (Liraglutide, Empagliflozin, Linagliptin)
Recruiting
- Type 2 Diabetes Mellitus
- Mild Cognitive Impairment
- Liraglutide
- +2 more
-
Nanjing, Jiangsu, China
- +1 more
Mar 28, 2022
Type 2 Diabetes Trial in Hortolândia (LID104, Dapagliflozin, Linagliptin)
Not yet recruiting
- Type 2 Diabetes Mellitus
- LID104
- +2 more
-
Hortolândia, SP, BrazilInvestigational site
May 23, 2023
Cognitive Protective Effect of Newer Antidiabetic Drugs
Recruiting
- Type 2 Diabetes
- Dapagliflozin
- +6 more
-
Alexandria, EgyptAlexandria University
Jul 24, 2022
Schizophrenia Trial in Reno (Linagliptin)
Completed
- Schizophrenia
- Linagliptin
-
Reno, NevadaUniversity of Nevada School of Medicine
Nov 5, 2020
Coronavirus Infection, Type 2 Diabetes Trial in Miami (Linagliptin, Insulin regimen)
Withdrawn
- Coronavirus Infection
- Type 2 Diabetes
- Linagliptin
- Insulin regimen
-
Miami, FloridaUniversity of Miami
Jun 7, 2021
Diabetes, Type 2, Left Ventricular Systolic Dysfunction Trial in Italy (Linagliptin, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Left Ventricular Systolic Dysfunction
- Linagliptin
- Placebo
-
Bergamo, BG, Italy
- +18 more
May 21, 2021
Diabetes, Type 2 Trial in Worldwide (Linagliptin, Empagliflozin, Placebo)
Active, not recruiting
- Diabetes Mellitus, Type 2
- Linagliptin
- +2 more
-
Phoenix, Arizona
- +82 more
Aug 23, 2022
Type 2 Diabetes, Coronary Artery Disease Trial in Graz (Linagliptin, Placebo)
Completed
- Type 2 Diabetes
- Coronary Artery Disease
- Linagliptin
- Placebo
-
Graz, AustriaMedical University of Graz, Department for Internal Medicine
May 14, 2020
Healthy Trial in Biberach (Empagliflozin/linagliptin/metformin HCl, Empagliflozin, Linagliptin)
Completed
- Healthy
- Empagliflozin/linagliptin/metformin HCl
- +3 more
-
Biberach, GermanyHumanpharmakologisches Zentrum Biberach
Feb 25, 2020
Healthy Trial in Biberach (Empagliflozin, Metformin HCl, Linagliptin (fixed dose combination), Empagliflozin, Linagliptin)
Completed
- Healthy
- Empagliflozin, Metformin HCl, Linagliptin (fixed dose combination)
- +3 more
-
Biberach, GermanyHumanpharmakologisches Zentrum Biberach
Feb 6, 2020
Type 2 Diabetes Trial in Hellerup (LY2403021, LY2403021 , Standardised liquid meal)
Completed
- Type 2 Diabetes
- LY2403021
- +6 more
-
Hellerup, DenmarkCenter for Diabetes Research, Gentofte Hospital, Copenhagen Univ
Apr 6, 2020
Diabetes, Type 2 Trial in China (, linagliptin, background therapy)
Completed
- Diabetes Mellitus, Type 2
- placebo
- +2 more
-
Beijing, China
- +24 more
Mar 24, 2020
Replication of the CARMELINA Diabetes Trial in Healthcare Claims
Unknown status
- Diabetes
- Linagliptin
- Sulfonylurea
-
Boston, MassachusettsBrigham & Women's Hospital
Jan 28, 2020
Type2 Diabetes, Albuminuria, Renal Insufficiency Trial in Seoul (Evogliptin, Linagliptin)
Completed
- Type2 Diabetes Mellitus
- +2 more
- Evogliptin
- Linagliptin
-
Seoul, Korea, Republic ofSamsung Medical Center
Sep 19, 2019
Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma Trial in Worldwide (5-Fluorouracil
Recruiting
- Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma
- 5-Fluorouracil (5-FU)
- +11 more
-
Scottsdale, Arizona
- +41 more
Jan 19, 2023
Real World Glycemic Effectiveness of Linagliptin
Completed
- Diabetes Mellitus, Type 2
- Linagliptin
-
Eden Prairie, MinnesotaOptum
Feb 1, 2019
Type2 Diabetes Trial in Seoul (Teneligliptin, Linagliptin)
Completed
- Type2 Diabetes Mellitus
- Teneligliptin
- Linagliptin
-
Seoul, Korea, Republic ofAsan Medical Center
Feb 20, 2019
Diabetes, Type 2 Trial in Japan (Linagliptin, Empagliflozin + linagliptin low dose, Empagliflozin + linagliptin low dose)
Completed
- Diabetes Mellitus, Type 2
- Linagliptin
- +5 more
-
Aichi, Nagoya, Japan
- +39 more
Sep 24, 2018
Schizophrenia Trial in Bandar Tun Razak (Linagliptin)
Terminated
- Schizophrenia
- Linagliptin
-
Bandar Tun Razak, Kuala Lumpur, MalaysiaPusat Perubatan Universiti Kebangsaan Malaysia
Aug 14, 2018
New Onset Diabetes After Transplant, Kidney Transplant; Complications Trial in Shanghai (Empagliflozin, Linagliptin)
Unknown status
- New Onset Diabetes After Transplant
- Kidney Transplant; Complications
- Empagliflozin
- Linagliptin
-
Shanghai, Shanghai, ChinaDepartment of nephrology, endocrinology and kidney transplantati
Aug 20, 2018
Chronic Kidney Diseases, Type 2 Diabetes Trial in Seattle (Linagliptin, Glipizide)
Completed
- Chronic Kidney Diseases
- Type 2 Diabetes
- Linagliptin
- Glipizide
-
Seattle, WashingtonUniversity of Washington
Sep 12, 2018